Abstract
Knitting is a versatile technology which offers a large portfolio of products and solutions of interest in heart valve (HV) tissue engineering (TE). One of the main advantages of knitting is its ability to construct complex shapes and structures by precisely assembling the yarns in the desired position. With this in mind, knitting could be employed to construct a HV scaffold that closely resembles the authentic valve. This has the potential to reproduce the anisotropic structure that is characteristic of the heart valve with the yarns, in particular the 3-layered architecture of the leaflets. These yarns can provide oriented growth of cells lengthwise and consequently enable the deposition of extracellular matrix (ECM) proteins in an oriented manner. This technique, therefore, has a potential to provide a functional knitted scaffold, but to achieve that textile engineers need to gain a basic understanding of structural and mechanical aspects of the heart valve and in addition, tissue engineers must acquire the knowledge of tools and capacities that are essential in knitting technology. The aim of this review is to provide a platform to consolidate these two fields as well as to enable an efficient communication and cooperation among these two research areas.
General characteristic of aortic heart valve and concept of smart scaffold
The aortic heart valve (AHV) is responsible for the unidirectional flow of blood out of the left ventricle, preservation of myocardial function and control of the coronary blood flow1. It closes and opens over 100,000 times a day and will function normally over the lifetime of a human being2. During this period, it is exposed to shear stress, bending forces, as well as strain and loading forces that are a result of its hemodynamic environment.
As a living, dynamic organ, it can adapt to its complex biomechanical and mechanical environment through passive and active communication between its constituent parts (see Figure 1)3. An example of passive communication is the influence of the shapes of the sinuses on forming the vortices that are important for valve closure and for maintaining coronary flow during systole. Active communication occurs when structures in each part of the valve (cusp, annulus, sinus, sinotubular junction) change shape, size and stiffness during specific parts of the cardiac cycle1. Such changes guarantee optimal ejection of blood from the left ventricle, valve opening and closure, adequate coronary perfusion as well as cooptation of the leaflets to prevent blood backflow into the left ventricle. This highlights the importance of using tissue engineering to develop heart valve substitutes that contain living cells and have the ability to assume the complex functions of the native valve.
The ideal smart scaffold should be non-immunogenic, resorbable and capable of attracting, housing and instructing cells to produce a particular phenotype5. It should also reproduce the performance and mechanical properties of the native valve, both in the short and long term.
Therefore, the smart scaffold is and for some time will be, the best option for developing a clinically relevant Tissue Engineered Heart Valve (TEHV) as it enables the remodeling of the construct with the patients’ cells and decreases greatly the possibility of a detrimental immune response5,6.
The main types of HV scaffolds currently being considered can be divided in two categories, namely, biological scaffolds and scaffolds based on synthetic polymers. The first category includes decellularised valves and whole organs7, decellularised non cross linked ECM6, amniotic membrane8 or scaffolds made out of alginate manufactured from sea weed9. The second type of intelligent scaffolds are made out of synthetic polymers10, including polyglycolic acid (PGA)11, poly (L-lactic acid) (PLL)12, copolymer blend PLGA13, Poly-ξ-caprolactone (PCL) and many others14. These synthetic polymers can also be enhanced with antibodies15,16, peptides17,18, aptamers19 and enzymes20 in a way that enables the scaffold to attract and instruct host cells, either from blood or surrounding tissue and induce them to differentiate to a tissue specific phenotype.
Using current state-of-the-art technology, it is most reasonable to focus on combining “the best elements” of the available strategies by constructing a textile-based scaffold with the required functionality and characteristics (Figure 2). The logic behind such an application of textile technologies is to utilize its advantages that have already been shown in the wide use of textile medical grafts in clinical practice. One major advantage of textile techniques is their utility in reproducing the anisotropic properties of the valve21,22.
Basics of knitting and its applications
Knitting is the process of manufacturing fabrics of interlooped yarns using hooked needles. The basic elements of the knitted fabrics are the loops. The loops can be closely or loosely constructed allowing them to be stretched in any direction, even if the yarn itself has low elasticity23.
The fabric can be characterized by the number of courses and wales per cm2. Course is a line of loops in the horizontal direction and wale is a line of loops in the vertical (Figure 3A2 and 3B2). A knitted fabric having more courses will be rigid and stable in length while a fabric with more wales will be rigid and stable in width.
There are two basic systems of knitting; the weft and warp knitting (Figure 3). In weft knitting, the yarns come from the horizontal direction, while in warp knitting the yarns come from the vertical direction. Each horizontal course in weft and vertical in warp knitting can be individually chosen (see Figures 3 and 5).
It is worth noting that weft knitting is useful for generating coherent objects stretchable in all directions with various choices of pattern, while warp knitting is more suitable for open net-like, branched structures with programmable directional elasticity. Therefore, for HVTE, warp knitting may be the technique of choice for leaflets, while weft knitting may be more useful to make a scaffold for sinus of Valsalva (see Figure 2). Additionally, because the nature of warp-knitted loops is more knot-like, the warp-knitted fabrics are more resistant to ripping. This particular aspect makes them more usable for medical textiles applications.
Usually, the weft knitting is performed by the so-called circular knitter machines, while warp knitting by flat knitting machines (Figure 4). Both types of machines are capable of fabricating tubular and even seamless garments. This is interesting from the point of view of HVTE, as the aortic root is a tubular object with a complex geometry (sinuses and leaflets, see Figures 1 and 2).
The most prevalent method of knitting 3D garments is to knit the bi-dimensional fabrics first followed by post-processing, e.g. by stitching to form the final geometry of the product. Currently, there is a strong trend in the direction of seamless garments (Figure 9)27. For that purpose, both weft and warp knitting could be used, however the advantage of warp knitting is that it can deliver hosiery (Figure 9E) or jackets with sleeves in one run while in weft knitting, sleeves and legs need to be attached separately.
Indeed, the seaming process makes fabrication more difficult to produce and more expensive. Nevertheless, the seaming methods are currently very precise and efficient, hence the necessity of seaming does not disqualify weft-knitting as a method to deliver complex 3D geometries such as a HV scaffold. Therefore, a compromise between complexity of process and required geometry of design should be made.
In principle, when using unconventional yarns (bioresorbable polymers for example) for fast prototyping, weft knitting is more advantageous since it requires, in its basic setting, only one cone of yarn, while warp knitting demands that each needle needs to have its own yarn. Thus, for warp knitting, a large number of cones/bobbins must be delivered to the knitting facility. As an alternative, the cone could be split, but this is a costly and a technologically advanced operation.
Table 1 outlines a summary of the differences between warp and weft knitting as well as the importance of the characteristics of each process for HVTE.
Table 1. Comparison of weft and warp knitting processes24 with comments on HVTE relevance.
Weft knitting | Warp knitting | HVTE relevance |
---|---|---|
Stretches in both directions | Stretches mainly width wise | This characteristic of dimensionally-specific stretch is critical for mimicking the anisotropic mechanical properties of specific layers of leaflets. |
Yarns can be supplied from single or few cones | Yarns must be provided from the warp beam | Warp-beam preparation is an expensive, time-consuming process and increases the “dead volume” of yarns (amount that needs to be loaded to machine prior obtaining the fabric. Weft knitting is advantageous for knitting with expensive yarns as it allows reducing their usage. |
Possible to knit with one yarn | Needs multiple warp yarns | Preparing the warp beam requires a large number of cones. Alternatively, the cone could be split. Splitting is a costly technological operation. |
Stable-fibre yarn can also be processed | Only strong filament yarns can be processed | Most biopolymeric yarns are in the form of filament; nevertheless, some may be disqualified for warp knitting due to insufficient strength. |
Less versatility | More versatility | For quick prototyping versatility may be less important than for final optimal design of HV scaffold. Noteworthy, 3D knitting (vital for HVTE) is done with weft knitting. The higher versatility of warp knitting relates here to available pattern rather than to shapes. |
Loops are not uniform | Loops are uniform | As long as variations in sizes of loop do not critically affect the properties of construct overall, both methods of knitting can be applied for fabrication of the HV scaffold. |
Dimensionally less stable | Dimensionally more stable | Dimensional stability is critical for preserving the designed geometry of the construct. |
Less expensive equipment | Expensive equipment | For R&D, the price of the equipment is a critical factor that needs to considered, especially if knitting services are outsourced. The machine owners will hesitate to test atypical/unknown yarns on expensive tools. It will be easier for them to accept the risk if circular knitting is performed to ensure yarn suitability for processing. |
Low running cost | High running cost | Expensive machines need to run continuously to pay back to the owner. It is easier to prototype with a low-cost machine. |
Short production runs | Mass production | Short production runs are more suitable for prototyping phases of the project. |
Less space required | More space required | For a laboratory environment, a compact equipment is usually preferred. |
Detailed classifications of knitting are presented elsewhere23,28,29 and only a few examples are shown on Figures 3 and 5. The most popular types of warp knitting include tricot, Raschel (see Figure 4) and stitch-bonding and for weft, these are single jersey, purl, rib and interlock types of stitches (see Figure 5)23.
From the perspective of HV scaffold construction, a very important characteristic of knitted fabrics is that they frequently have two distinguishable sides (compare Figure 5A1 to 5A2, showing two sides of same fabric sheet) varying in term of texture and properties. This needs to be considered when designing the scaffold as texture may affect its blood compatibility30. The difference in properties of each side will often depend on the type of knitting chosen. For example, interlock stitch will provide a rough surface while a surface of velvet with closed loops will be very smooth.
Another important specification of knitting is related to its scaffold coding capacities. The coding concerns the possibility of involving a specific yarn in a specific place of the construct. This provides additional precision that could be used to control the type of surface on which the cells are seeded and manipulate the cells interacting with the scaffold. Jacquard knitting (Figure 6) is one of these techniques that can create a hybrid structure consisting of several types of yarns capable of precisely controlling cell growth. In Jacquard knitting, the needles of knitter can be manipulated individually, providing virtually endless options for obtaining specific patterns.
Also in the case of Jacquard knitting, its limitation is that face and reverse sides of fabrics could be dramatically different in appearance and properties. This may be critical for leaflets, since each side should be carefully designed for cell/polymer specific interactions. This can be overcome by the lengthwise coding of a yarn prior to the knitting32,33.
Another unique and important technique available in knitting is warp-stitch-bonding. It is commonly used to design composite materials, when knitted loops are used as a knot between elements. It can be particularly useful for combining the knitted structure with an enforcing “jacket” to further improve long-term dimensional stability of the construct (see Figure 7).
A striking type of knitting is a laid-in stitch, which can be used to precisely design the direction of stiffness and elasticity (see Figure 8) within the leaflet and HV. This, as a consequence, prevents deformation in a given direction. This technique could be applied to make hybrids for specific applications. For example, if the laid-in yarn is non-degradable, while the other yarn is biodegradable, the resulting scaffold could be remodeled as the ECM is being formed, while the non-degradable yarns will provide the permanent support.
Perhaps the most efficient way to increase awareness of the several techniques and advances in knitting technology among tissue engineers is to present several common knitted products and discuss opportunities arising from solutions specific to them. Some examples can be seen in Figure 9, which includes shoes, socks, gloves, bras, sport suites and sharkskin-inspired swimsuits.
Sports shoes (Figure 9A) are constantly exposed to dynamic mechanical stresses. Due to this, multiple areas with specific knitting patterns need to be adjusted in order to transfer the forces from the feet to the sole without damaging the body. Similar challenges can be identified in HVTE. In Figure 9B, there is an example of a flat fabric enforced with yarns to form a 3D shape; a similar concept can be used to produce a fibril network enforcing the leaflets.
Knitted seamless gloves (Figure 9C) have a complex geometry, thus the machines that are used to make them could potentially be adopted to fabricate HV geometries. Bras (Figure 9D) are made by 3D deformation of flat knitted patches draped on a mold35. This could be applied in HV to obtain leaflets and sinuses from a tube. Another way to obtain tubular shapes for HV could involve the technology used to obtain knitted hosiery that can have a variety of patterns (Figure 9E) in one run.
The manufacturing of socks (Figure 9F) is also interesting, since they are made by combining different knitting patterns and the method of shaping the heel could be used to make the sinuses of HV. Knitted swimming suits (Figure 9G) are inspired by sharkskin (Figure 9I) to reduce resistance of water by using a specific pattern on the fabric face side (Figure 9H). This may be particularly useful to achieve specific surface/blood interaction on a given place of HV scaffold.
After manufacturing, the fabric needs to go through finishing processes to ensure that it is usable. Finishing of knitted textile include a range of techniques that includes mechanical finishes, heat setting, chemical processes and coating23.
Mechanical processes include calendaring, raising and cropping. Calendaring is performed by compressing the fabric between two rolls and it provides a smooth, flattened appearance to the surface of the fabric. Raising is a type of mechanical process based on plucking the fibers from a knitted fabric in order to give a nap effect on the surface. Cropping aims to provide a smooth appearance to the fabric by shaving the surface hairs23. From a HVTE perspective, calendaring could be used to provide a smooth surface where blood could flow undisturbed; raising may be used to create a spongiosa-like layer on the fabric; while cropping may be used to create a specific pattern on the surface by trimming the raised fibres.
Heat setting is a process used to stabilize synthetic fibers so that they do not shrink upon heating. During the heat setting phase the amorphous and crystalline areas of the bulk yarn-polymer are rearranged, which could be used to model the construct into a specific shape. This process is frequently used for medical grafts in the final stage to shape them, and includes three steps; namely, (I) heat the fabric to within about 20–40°C of the fiber melting point, (II) hold at this temperature under the tension for approximately 20s, and (III) cool the fabric before removing tension23.
Chemical processing is the most important way of finishing a knitted structure for HVTE. Usually, chemical finishing involves the application of chemicals that are flame retarders and water repellants. When it comes to HV scaffold, chemical processing could be used to improve the polymer interactions with the body, such as reducing the immunological response and thrombotic effect, as well as enhancing cell specific scaffold interactions15,16. Prior to chemical processing, it is important to wash the fabric to remove coatings and dirt that may result from yarn production or from the knitting process.
Surface coating is currently the most prominent way of finishing medical textiles. Synthetic grafts have been coated with proteins such as collagen, fibronectin or polysaccharides including heparin to avoid graft thrombosis, mismatched compliance and anastomotic intimal hyperplasia. Depending on the proteins used, the coated grafts demonstrated better cell attachment in vitro and improved patency in vivo45–48.
Three-dimensional knitting: Achievements and potential for HVTE
In principle, all of the above-discussed garments (with the exception of bras) are flat structures that only adopt a 3D geometry when stretched onto or around an object – the human body for example. An alternative to this method is 3D knitting. 3D knitting confers better manufacturing and mechanical properties since it provides a ready-made 3D structure without a need for structural support. Therefore, 3D knitting is important for HV engineering since the 3D structure of the valve must be sustained even without the pressure of blood. Similarly, the native valve is an elastic structure, which should not collapse when removed out of the heart. Thus, this branch of knitted textiles may yield the structures that are the most relevant to HV geometries2.
Weft knitting, so far, has proven to be the most versatile method when it comes to 3D knitting31. Regarding machine type, the flatbed machines are superior over the circular knitters as they can provide multiple types of tubes and enable rib transfer, thus variations in the width and circumference of 3D forms may be achieved (Figure 10). Another important consideration is that to develop challenging geometries, the equipment needs to be controlled by cutting edge software. Important breakthrough research on modeling knitted clothing with yarn-level detail was presented by Yuksel and colleagues in 201249.
Surprisingly, manual crocheting could also yield spherical seamless shapes but this process has not been yet automated, most likely due to economically insufficient market demands. Nevertheless, it is a possible alternative that needs to stay on the radar of TE.
Knitted medical devices
Vascular grafts, cardiac nets and hernia meshes are leading the market of currently applied medical textiles. In the heart valve industry, the knitted structure is mainly used as a cover for the ring to enable suturing the valve to tissues. Nevertheless, some examples of knitted-assisted HVTE in their pre-clinical phase were reported50–53, which will be outlined below.
Knitted grafts are built of the filament loops that are continuously interconnected and spirally aligned around the graft circumference. Both weft and warp knits are used for graft design. Knitted structures are softer, more compliant, more flexible and easier to handle than woven structures. Weft-knitted structures have more stretch than warp knits, and therefore are inherently less dimensionally stable. Commercially available knitted implants do not vary much in their structure, thus the versatility of knitting technologies has not been fully exploited yet. The grafts used are mainly a plain-knit single layer homogenous structure, hence, more studies on making them aorta-like are in progress54. To the authors’ knowledge, no bioresorbable polymers have yet been used to make a clinically applicable graft. Polyethylene terephthalate has been been, so far, almost the only material used for commercially knitted grafts55, however there is a problem concerning its application because its mechanical behavior is significantly different to that of natural arteries56.
Another example of knitted medical textiles are nets for cardiac support, for example CorCap (Acorn Cardiovascular Inc., St. Paul, MN, USA)57. CorCap is a warp knitted fabric mesh implanted around the heart to provide circumferential diastolic support and limit negative left ventricular remodeling by reducing ventricular wall stress (see Figure 11).
One of the most commonly used knitted medical textiles are meshes for repair of recurrent and primary inguinal hernias. The nets are made of polypropylene or polyvinylidene fluoride (PVDF), monofilament yarns using warp knitting – with tricot and Raschel stitch (see Figure 3).
For patients with aortic dilation, a textile medical device that halts or reduces aortic root dilation has been developed and marketed by Exstent Ltd (Tewkesbury, UK). The Personalised External Aortic Root Support is a PET/Polyester textile mesh formed to the geometry of the individual patient’s aorta.
During the implementation procedure, the chest is opened, the aorta is dissected out of the adjacent structures, and the mesh is implanted around it59. Importantly, dissection of the aorta does not include cutting through its diameter/width, but only extracting the aorta from surrounding tissues59. What makes this device unique is its high level of personalization. Spatial data from magnetic resonance imaging (MRI) or computed tomography (CT) images are used to create a CAD model from which a replica of the individual’s aorta is made by 3D printing. On this mandrel, a mesh support is formed and immobilized by suturing it proximally to the left ventricular outflow tract (LVOT) and looping its distal end around the Brachiocephalic root. The implant forming process (probably textile thermo fixing) ensures the preservation of scaffold’s shape after removal from the mandrel59. Another very positive aspect of the ExoVasc device for personalized external aortic root support (PEARS) is integration with host tissue, which was confirmed in an animal model (Figure 13)60.
Fabric internalization is very important in regards to smart scaffold technology since the polymers must be not only integrated but also even finally bioresorbed. The authors reported no aortic or aortic-valve events in 63 treated patients, of which 30 were monitored for almost nine years after implementation. Comparing it to a standard root replacement procedure of implementing a mechanical valve, the PEARS was found to be superior as it had not caused any thromboembolic event. To support this statement authors declared further studies including a larger group of patients59.
One concern related to PEARS was that an aorta reinforced from outside will become thinner over time as its exposure to mechanical stimulus is restricted. In the case of PEARS, no thinning of the aorta was observed in humans61; in fact, animal studies showed thickening of the aorta60. One possible explanation could be that within the support the aorta is less exposed to diametral/tensile deflection, but wall compressive deflection compensates for this reduction. The macroporous mesh is intimately incorporated into the outer layers of the aorta, permanently fixing the fabric in place. Dilatation beyond the mesh has not been observed, but should be regarded as a significant risk - as confirmed during the animal studies (Figure 13G). Perhaps an improvement would be to use bioresorbable yarns, or/and decorating the yarns to enable recruitment and housing of specific cells migrating from the aorta.
Knitting-assisted HVTE
Both weft and warp knitting were utilized to develop heart valves prosthesis for research purposes.
In 2006, the Baaijens’ group reported tests performed on knitted tricuspid valves50. A multifilament (220 dtex f44), polycaprolactone (Mw 50,000) yarn, Grilon KE-60 (EMS Griltech, Domat, Switzerland) was used for the double-bed weft-knitting of a rectangular patch with three half-round pockets (see Figure 14). The same yarn was used to suture the patch into a tube. To clean the yarns, the scaffold was washed with water and soap prior to sterilization in ethanol. The scaffold was pulled on the valve-shaped-mold and a mixture of fibrinogen and thrombin was poured over the scaffold for gel formation. The gelation was repeated until the knit looked fully covered by fibrin. The scaffold was released from the mold and tested in pulse duplicator system, where it survived 1 million open-close cycles with no fabric rupturing.
This early work established a milestone for the textile-assisted HVTE, the importance of which is unquestionable. However, there are some drawbacks of this approach, which need to be discussed for the benefit of ongoing research. One major issue is that the knitted structure does not preserve the geometry of the valve, since fibrin-gel can be easily washed out of the yarns, as reported in Baaijens’ paper50. Therefore, due to the possibility of leaks, the geometry and performance of the valve may become unstable over time. This limits the possibility of hydrogels being used as a binder for the yarn, but they could still play a role as a shock absorber, lubricant and/or cell housing medium. Based on these considerations, a better use of the hydrogel in the structure of leaflet could be in the spongiosa62. At this location, the hydrogels should be well protected by yarns and nanofibril structures (see Figure 2) of the surrounding biopolymer. This protection needs to last long enough to enable recruited cell growth and glycosaminoglycans (GAGs) synthesis.
Baaijens et al50 cultured the cells on scaffold made out of the yarns; however the interaction of the cells with the yarn was not mentioned. This is unfortunate because the alignment of the cells lengthwise to the yarn and subsequent ECM orientation is crucial for designing the anisotropy of the leaflets63,64. The utilisation of bioresorbable polymer (polycaprolactone, PCL) for knitting was the pioneering step towards developing the concept of intelligent scaffold and successfully continued by Baaijens later65,66.
Based on the pioneering studies of Baaijens et al.50 on the PCL scaffolds, preliminary tests of human mesenchymal stem cells (MSCs) culture on PCL threads (made by the present authors) showed the longitudinal alignment of cells along the yarn (Figure 15).
Much more recent examples of applications of knitted fabrics in HVTE are reported by Mela’s group51–53. In these cases, the fibrin constituting the leaflets of valves is enforced using a warp-knitted tubular mesh made out of polyethylene terephthalate (PET). In all three reports, the authors evaluated biocompatibility of the construct by encapsulating the cells in the fibrin gel constituting the leaflets and quantifying the secreted ECM proteins. Other authors reported that in vivo implantation with fibrin-based tissue-engineered heart valves67,68 revealed an absence of calcification, thrombus formation, aneurysm development or stenosis. After 90 days of implantation, it was also observed that a monolayer of endothelial cells was formed68 which exhibits the promise of fibrin scaffolds for HVTE.
Nevertheless, it is not clear if this approach will be adaptable for the intelligent scaffold, as in the smart solutions, the cells need to be in situ recruited from blood and surrounding tissues.
Moreover, PET is not a bioresorbable material, thus alternative strategies need to be proposed to enable growth of valve tissue within the patient. For example, warp-beam can be set with alternating PET and PCL yarns, therefore the hybrid scaffold will be continuously enforced by PET and still able to grow after PCL degradation.
Furthermore, the leaflets are stitched to the silicone tube that simulates the valve (sinuses of Valsalva ). From an experimental point of view, this is an advantage as leaflets can be observed from the side; nevertheless, more work is needed on combining the leaflets into the implantable graft.
In summary, the solutions proposed by Mela and colleagues are promising and encouraging. To actively support this statement, we fabricated leaflets using special PET knitted fabric.
Cell colonization in knitted fabrics
Porous 3D structures are used to support and guide the ingrowth of cells into the matrix during colonization69. In this section, we summarize various factors affecting cell colonization in the three-dimensional environment of knitted fabrics. Cell70,71 material interactions (adhesion and mechanotransduction), scaffold properties such as porosity72, pore size, void fraction73,74, fiber thickness, topography and scaffold stiffness75 all play key roles during colonization.
Porosity
Porosity is a measure of the open pore volume within the matrix, often called the void fraction; it is the ratio between open volume and total volume of scaffold. Knitted textiles are inherently a macroporous structure due to their loop-based nature76. The size of the loop can be adjusted, but the minimal size is governed by the size of needle used for knitting. Moreover, porosity, types of pores and pore interconnectivity can change dynamically upon exposure of the fabric to mechanical stress. It is acknowledged that pore size affects cell attachment, migration, depth of cellular in-growth, phenotypic expression and cell morphology77.
The optimal pore size range depends on the materials as well as cell types78; outside this range, cells fail to spread and form networks. For example, endothelial cells (ECs) are able to colonize scaffolds with pore sizes <300 µm79–81. The “safe pore size range” for supporting cell ingrowth for the majority of mature cells is in the range of 100–150 µm81. Obviously, the porosity of yarns used for knitting is an important factor to consider especially for multifilament yarns. Filaments packed in yarn will provide the fabric with pores or/and channels oriented lengthwise to the thread. One may hypothesize that these channels can be used to drive oriented cellular growth and ECM deposition. In general, it is reasonable to expect that the knitted structure will leak in contact with blood. To prevent leaking, a coating may be applied on scaffold using ECM30, hydrogels51, nanofiber meshes82 or polymer films. Therefore, the macroporous nature of knitted structures enhances polymer cell interaction, good contact with blood and enables cellular colonization of the structure.
Filament/fiber thickness
An important parameter in knitted scaffolds is the microscale thickness of the individual material filaments in the yarn. The filaments in knitted structures are usually highly organized with regular repeating pore units (at fabric relaxed state). The filaments’ thickness, length, width and shape (circular, rectangular, etc.) will play the role in cellular colonization of fabrics. It was previously demonstrated that fibers (700nm in diameter) of oriented polycaprolactone nanofibers promoted phenotypic differentiation of chondrocytes compared with 2D nonporous membranes83. Cells maintain phenotypic shape and guided growth according to nanofiber orientation of oriented fibrous structures on which they are seeded. Scaffold fibers orientation may enhance the ECM proteins synthesis84. Further studies are necessary to verify if the orientation of filaments in the yarns may affect cellular colonization in a similar manner22.
Filament topography
The surface characteristics of yarns constituting the knitted scaffold can be described by its topography, comprising of micro- to nano-scale material surface features. The topography of the yarn surface may influence the spreading characteristics and activity of cells85. The extrusion-based method of filament production provides the filaments with grooves, pores and other lengthwise homogenous topographical features. It was shown that grooves may reshape actin filaments to adjust to the new topography86, or inhibit cell movement and bend the cell cytoskeleton85. Surface roughness can significantly increase the cell migration area87 and improve the adhesion and growth of cells88 on polymer scaffold89. Another way of modifying the yarn surface is by the inclusion of nanoparticles or by etching the surface of the matrix88,90.
Stiffness of knitted structures
The resistance of the material to deformation (stiffness) influences cellular activity91,92. Cells show reduced spreading when soluble adhesive ligands are not strongly attached to the surface93,94, as scaffolds are unable to withstand cell contractile forces92. The stiffness of the knitted construct can be increased by heat-setting the fabric23; this needs to be performed carefully since an elevated temperature may permanently melt and join filaments of the knitted yarn together and change porosity. Raising23 is another finishing technique that may be used for changing the structure and properties of the material, such as enhancing cell /polymer interaction on a given side of the fabric.
Mechanotransduction in knitted structures
Since knitted structures are more elastic than woven ones, the seeded cells would sense more stretch and deformation when the knitted fibres are subjected to stretching. Studies have shown that both mechanical stresses95 and hydrodynamic stresses96 affect cell colonization. Shear stress initiates multiple signal transduction cascades leading to functional changes in endothelial cells23. Endothelial cells grown in a perfusion reactor have been shown to align in the direction of flow97. Mechanical forces may unfold selected protein domains, thus providing access to a different set of binding sites or trigger opening or closing of ion channels98.
Cells experience local shear stress rates when flow through the scaffold microarchitecture occurs. The scaffold architecture controls the transport of nutrients within the samples. However, the dynamically changing geometries of knitted structures may result in flow irregularities, extracellular matrix washout or local hypoxia98. The presence of flow within a reactor also affects the production of ECM components. Therefore, the flow that the scaffold is subjected to in a bioreactor must be closely regulated to control cell seeding and ECM production.
Cell adhesion on the yarn surface
Another aspect that influences the interaction of the knitted scaffold with the surrounding environment is the yarn surface. Cellular adhesion, proliferation and differentiation can be enhanced by anchoring to the scaffold surface specific cellular binding sites99 or incorporating into the scaffold growth factors100,101.
The knitted structures are often used in a hybrid format with hydrogel; namely, collagens, glycosaminoglycans (GAGs)102,103, alginates or fibrin gel50–53. The hydrogel is used to host the cells and enable their proliferation but it can also be loaded with drugs or agents responsible for scaffold remodeling. One elegant example of such use of hydrogel was reported by Baaijens, who loaded hydrogels with fast-releasing monocyte chemoattractant protein-1 (MCP-1). MCP-1 released from the gel triggered inflammation-mediated tissue remodeling104.
Another vital method of modifying the properties of yarn surfaces is culturing cells on them. For example, mesenchymal stromal cells (MSC), when seeded on a scaffold secreted a cocktail of trophic factors including MCP-1, which initiated a cascade of immune responses culminating with tissue remodeling on scaffold105. This strategy has not been applied yet for knitted fabrics but there are no obvious obstacles to do so.
The overall efficiency of cellular colonization of knitted fabric is related to structure and degradation rate of polymers used as yarns. For example, biodegradability decreases with increase in molecular weight106. A similar decrease of biodegradability is associated with denser structure of the crystalline sample, since it would be more impermeable to the enzymatic attack107.
Importantly, as reviewed elsewhere69, the structural, biological and degradation properties of the EC matrix also are key factors regulating colonization.
Basic methods for characterizing knitted scaffold
The following section will focus on specific requirements for tissue-engineered constructs that textile specialists need to understand. This is important because obstacles encountered during the scaffold preparation need to be addressed in a manner that would not affect the requirements for its final application. For example, for textile engineers the obvious way of providing 3D geometry to the fabric is to seam the material. However, from the perspective of tissue engineers, stitches in the construct may be beneficial (as a local enforcement), but in other occasions, stitching may need to be avoided, especially if homogeneity of the fabric is desired.
Standardized methods for HV scaffolds characterization
The critical parameters of a scaffold and its characteristics are precisely described in the official regulations of International Organization for Standardization (ISO). For example, ISO 5840, entitled Cardiovascular implants – Cardiac valve prostheses, consists of three parts: General requirements108, Surgically implanted heart valve substitutes109 and Heart valve substitutes implanted by transcatheter techniques110.
According to ISO 5840, the heart valve substitute should meet following basic conditions:
-
•
allow forward blood flow with acceptably small pressure difference,
-
•
prevent retrograde flow with acceptably small regurgitation,
-
•
be biocompatible,
-
•
be resistant to haemolysis,
-
•
resists embolization and thrombus formation,
-
•
compatible with in vivo diagnostic techniques,
-
•
deliverable and implantable in the target population,
-
•
remain fixed once placed, have acceptable noise level,
-
•
have reproducible function, maintain its functionality for a reasonable lifetime,
-
•
consistent with its generic class and also maintain its functionality and sterility for a reasonable shelf life prior to implantation.
These regulations concern all the components of the heart valve substitute.
Fluid mechanical performance
Hydrodynamic testing is used to ascertain information on the fluid mechanical properties within the valve. The testing provides indicators of valve performance in terms of load to the heart, and potential for blood stasis and damage, which is important from the point of view of risk assessment. The tests should include steady flow testing, pulsatile flow testing, and steady leakage flow testing. Where applicable, testing should be performed using a test fluid of isotonic saline, blood or a blood-equivalent fluid whose physical properties (e.g. specific gravity, viscosity at working temperatures) are appropriate to the test being performed. The risk assessment shall play a role in the choice of the test fluid.
Valve lifetime estimation
The durability assessment allows an estimation of the proper function of the scaffold over its lifetime. The testing should prove that the heart valve substitute (in case of a flexible one) will remain functional for 200 million cycles. During the durability testing, the defined target peak differential pressure across the closed valve shall be maintained for 95% or more of all the test cycles. The testing should also be conducted under in vivo conditions for fatigue performance of the heart valve substitute and all its components to determine the structural life time of the material.
Preclinical tests for heart valves
Preclinical evaluation in vivo should be focused on heamodynamic performance of the heart valve assessed via in vitro testing, surgical handling of the scaffold and its accessories, and various biological reactions of the material with the tissue, mainly:
-
•
healing characteristics (pannus formation, tissue overgrowth)
-
•
haemolysis
-
•
thrombus formation
-
•
embolization
-
•
foreign body reaction (inflammation, rejection)
-
•
calcification (flexible valves)
-
•
acoustic characteristics (rigid valves), if manufacturer claims are made on this issue
-
•
structural deterioration and/or non-structural dysfunction
-
•
cavitation
Biocompatibility of materials and components in the heart valve
Biocompatibility of materials and components used in heart valve substitutes should be determined in accordance to guidelines described in ISO 10993-1. During the hazard identification stage of a biological safety evaluation, the information obtained should be sufficient to allow identification of potential toxicological hazards and the potential for effects on relevant haematological characteristics. For heart valve substitutes using animal tissue or their derivatives, the risk associated with the use of these materials should be evaluated in accordance with EN 12442-1/2/3:2008.
Other properties of materials and components in the heart valve
From the point of view of material performance and risk assessment, it is crucial to know the basic properties of materials after processing and modifications. The evaluation should include bulk, surface, chemical, and mechanical properties of material. All measurements should be performed on materials or components as they would be found in the finished product. This includes all subsequent treatments after the fabrication.
The evaluation of textile scaffold bulk properties includes: identification of materials in scope of the chemical composition and purity, density, porosity as well as permeability, microstructure e.g. defects formation, glass transition temperature, melt index, melting point, hydraulic expansion and biostability in physiological fluids.
For the modified scaffold, important assessment methods should include:
-
•
surface chemical composition
-
•
surface topology/roughness
-
•
surface charge and charge density
-
•
critical surface tension
All the measurements should be performed after all treatments e.g. sterilization, as these may physically affect the surface properties of the material.
Mechanical and chemical engineering properties allow the evaluation of the performance of the heart valve scaffold in the intended site and also provides information on the possible risks resulting from scaffold processing and materials used. These properties include: wear resistance, friction coefficient, peel strength, flexural and compressive strength, tensile strength, tensile strain to failure, strain energy to failure, residual stress, stress relaxation, fracture toughness, crack growth velocity, fatigue life, potential stress corrosion, tear strength, Young’s modulus, Poisson ratio, dynamic moduli including storage and loss moduli.
Nevertheless, in the early stages of scientific development and proof of concept communications, the spectrum of analysis should be narrower, as its aims are to enable scientific discussion, open ideas for critique and make subsequent improvements.
Tissue engineering cannot be dissociated from relevant clinical standards and related safety issues. Therefore, it is especially important to develop a good understanding of the limitations that need to be addressed111. To illustrate this with an example, when it comes to knitting the HV scaffold with bioresorbable PCL yarns, the following issue should be noted. PCL has a low melting temperature, therefore devices made from it cannot be autoclaved. Also, sterilization via high-energy irradiation may rearrange the chemical bonds in PCL. This will affect biocompatibility and degradation rates112. Moreover, immediately after implementation, PCL starts to degrade. It is reasonable to expect quicker degradation in places subjected to higher dynamic mechanical stress. Perhaps at these locations, the scaffold will need to be enforced by less fragile polymers. Regions of the scaffold unoccupied by cells may degrade and yield short fibrils that will circulate in blood. It is not clear if, in that form, the PCL would degrade quickly enough to avoid a build up of plaques inside the veins.
Basic mechanical tests of HV scaffolds
There are several methods to mechanically characterize scaffolds for HVTE. Usually, the first tests involve tensile testing. Tensile testing is mainly performed in a uniaxial machine, but it could also be done biaxially. This test gives a measure of the sample’s elastic modulus (stiffness, E), ultimate tensile strength (UTS), strain-to-failure (εf), yield stress and yield strain. Several studies113–115 determined average values for these properties in native valves, which are displayed in Table 2, where circ is the circumferential direction and rad is the radial. It is important to remember that the leaflets contain collagen fibers that are not initially straight. As the tensile test progresses, the fibers will be stretched until they are straight, which will require higher stresses. This will translate to an initial region in the curve where the modulus is low, which will develop to an elastic region with higher modulus, when the collagen fibers are straight. The values of moduli displayed in Table 2 correspond to the region where the fibers are already straightened.
Table 2. Typical values obtained from tensile testing for native valves.
Sample | Ecirc (MPa) | Erad (MPa) | Ecirc/Erad | UTS circ (MPa) | UTS rad (MPa) | εf circ (%) | εf rad (%) |
---|---|---|---|---|---|---|---|
Sheep AV114 | 3.84 | ∼0.2 | ∼19,2 | ∼2 | ∼1.5 | ∼20 | ∼50 |
Fresh porcine AV leaflets117 | 54.6 ± 7.4 | 7.82 ± 0.58 | ∼7 | 6.25 ± 0.9 | 1.18 ± 0.09 | 30.8 ± 3.2 | 62.0 ± 3.5 |
Porcine AV leaflets118 | 28 ± 10 | 1.33 ± 0.42 | ∼21 | ||||
Porcine AV116 | 3.35 | 1.09 | 3.2 | ||||
Human AV116 | 3.52 | 2.27 | ∼1.6 | ||||
Porcine ventricularis | 7.41 × 10−3 | 3.68 × 10−3 | ∼2 | ||||
Porcine fibrosa119 | 13.02 × 10−3 | 4.65 × 10−3 | ∼2.8 |
Studies on knitted scaffolds have to be able to achieve similar values to the native valve in tensile testing. Table 2 shows a great range in the values of elastic modulus for heart valves. This could be explained due to species variability, however even when comparing studies in porcine valves, the highest value for circumferential elastic modulus is 20x higher than the lower value116,117.
Lee et al. used strips of 5 mm (circumferential) and 8 mm (radial), explaining that strips with less than 4 mm and 6 mm in width, respectively, did not produce a stable response after preconditioning with cyclic loading and eventually failed, therefore they could not be representative of the in vivo structure117. This should be taken into account when undertaking mechanical tests, since the preconditioning must be appropriate. Sauren et al. found that it is necessary not to exceed the first elongation in subsequent cycles to achieve the required preconditioning118. It was also found that aortic valves are preconditioned after a maximum series of ten cycles.
Another important mechanical test, especially for knitted scaffolds, is burst strength. This test exposes the sample to increasing pressures until structural failure occurs, a moment characterized by a loss in pressure. Table 3 displays several values for the burst strength of the scaffolds.
Table 3. Values for burst strength of different scaffolds.
Material | Burst strength (mmHg) |
---|---|
Fibrin without textile reinforcement51 | 44.0 ± 18.5 |
Fibrin with textile reinforcement51 | 90.7 ± 14.0 |
TexMi valves51 | 554.7 ± 92.2 |
Native ovine mitral valve51 | 5272.3 ± 538.0 |
Tube-in-stent PET textile with fibrin53 | 146.1 ± 46.0 |
Tube-in-stent PET textile with fibrin after cultivation53 | 321.1 ± 30.9 |
Tube-in-stent PET textile with fibrin after cultivation and crimping53 | 334.7 ± 34.3 |
TexMi is a mitral valve scaffold made with fibrin in a knitted PET structure53. The knitted structure doubles the strength of the fibrin scaffold to 90 mmHg. This increase is greatly enhanced by the TexMi design to a value of ∼555 mmHg. However, this value is still significantly lower (only 10%) than the one obtained for ovine mitral valves. In the tube-in-stent fibrin-based PET knitted scaffold made by Moreira et al.53, a burst pressure of 146.1 ± 46.0 mmHg was measured. After the cultivation with endothelial cells for 21 days, the valves were crimped from 22 mm to 8 mm and kept in the crimped state for 20 min before returning to the original size. The test was performed again and the burst pressure before crimping was increased to 321.1 ± 30.9 mmHg.
After crimping, the value did not significantly change. This is an important consideration, because during the implantation of the valve, crimping will occur, and this has been shown to damage the collagen and endothelial layer120. The similar results for burst strength before and after crimping obtained by Moreira et al.53 can be explained by the reduced time in the crimped condition. Therefore, when designing a knitted scaffold, the effect and duration of crimping must be taken into consideration to see if the damage to the endothelial layer will significantly decrease the mechanical properties.
Finally, the mean pressure gradient and regurgitation of the knitted scaffolds must also be evaluated. The measurements of the pressure must be performed upstream and downstream of the valve at aortic conditions: 80-120 mmHg aortic pressure (100 mmHg mean), 70 bpm frequency, 5L/min cardiac output in a pulsatile flow53. Commercially available transcatheter aortic valve implantation (TAVI) systems have a mean gradient of 9.3 ± 4.5 mmHg121. A similar value was obtained with the tube-in-stent knitted PET with fibrin53 that had a mean pressure gradient of 7.3 ± 1.5 mmHg before and 6.8 ± 1.7 mmHg after crimping, values that were statistically not significantly different. The regurgitation was 15.1 ± 2.5 % before and 15.3 ± 3.6% after crimping, below the 20% limit defined by ISO 5840:2012 for a 23 mm valve replacement. In the knitted fibrin-covered PCL scaffold described by Lieshout50, the regurgitation was 39 ± 3%, due to fibrin-related leakage. This value is unacceptable, therefore the method and materials used to create this scaffold need to be revisited.
Basic biological tests of HV scaffolds
In addition to assessing mechanical properties, the ability of the scaffold to attract and grow cells that will produce the ECM matrix must also be studied. This includes, after culture with the desired cells, histology studies, immunohistochemistry, ECM content assays, and microscopy techniques such as scanning electron microscopy (SEM).
Endothelial cells, smooth muscle cells (SMC) and fibroblasts are some of the cells used for culture of scaffold for HV. The source of the cells to be isolated is an important factor. It has been shown that tissue engineered vascular constructs made with arterial cells developed a significant synthesis of elastin that did not occur in the constructs made with venous cells122. Elastin plays an important role in the elastic deformation of valves, and in HVTE elastin is hardly formed in vitro123. However, the TexMi scaffold51 showed a significant synthesis of elastin in the stress lines with cells from ovine umbilical veins, while cells from ovine umbilical arteries did not produce elastin. Therefore, the cell source is a meaningful variable in culture of scaffolds for HVTE. Cell culture ideally should be performed in dynamic cultivation, in a bioreactor for conditioning and to obtain the proper phenotype. After 21 days, ECM production is expected to occur. The protocol varies, for example, TexMi51 uses 5 days in static cultivation, 6 days at 30 bpm, 6 days at 40 bpm and 2 days at 60 bpm, while tube-in-stent53 uses 7 days in static cultivation, then 14 days in dynamic conditions that varied from 20–35 bpm.
For the histology, the scaffold should be fixed, embedded and sectioned after culture. Morphology of the tissue can be analyzed by using Hematoxylin and Eosin (H&E) stain, and tissue development can be analyzed by Gomori’s Trichrome stain. H&E should show a homogeneous distribution of cells across the scaffold’s thickness and Gomori’s Trichrome, in the context of HVTE, should show the presence of collagen fibers.
In immunohistochemistry, the tissue should be incubated with antibodies that stain against α-smooth muscle actin (α-SMA), collagen I, collagen III, elastin, GAGs, CD31 (endothelial cell marker) and fibrinogen. Culture on TexMi51 produced type I and III collagen longitudinally across the thickness of the scaffold. In the native valve, collagen is the main ECM protein. Collagen content can be assessed by a hydroxyproline assay124. SEM should be used to analyze if a homogeneous layer of cells was obtained. In the case of crimping53, SEM will be particularly useful to determine the amount of damage to the endothelial layer.
Basic tests of the knitted fabrics
From the perspective of knitted textile characterization, the list of pivotal parameters and measurements includes; thickness, surface mass, burst strength and identification of fibers in textiles.
Thickness should be evaluated according to ISO 5084-1999 Textiles - Determination of Thickness of Textiles and Textile Products and surface mass should be evaluated according to PN-EN 12127:2000. Reduction in the above-mentioned parameters improves the long-term biocompatibility of scaffolds125. Those parameters are crucial as they influence material elasticity. Scaffolds need to be elastic and conformable, on the other hand should not be too flexible as this could cause the knitted fabric to curl.
To alter the properties of fibres, many producers use chemical modifiers during the fibre forming process. Hence characterization and analysis of the chemical constitution of a fibre are essential to secure safe usage of scaffolds. It is important to determine all types of fibers present in a sample of textile material of unknown composition. The standard outlining analytic methods used to determine chemical composition of textile material is ASTM D276 “Standard Test Methods for Identification of Fibers in Textiles”. This standard only allows identification of the generic types of fibers present in a sample of textile material of unknown composition.
Since knitted woven fabrics contain oil, lubricants and delustrants, an integral part of the production process, but unacceptable in medical products, the appropriate surface cleaning method should be applied. Van Lieshout et al.50 proposed a simple method of removing contaminants from yarn. To dispose of the antistatic build-up layer of oils, the scaffold sample was washed in soap water for 24 hours, flushed with water extensively, and shaken in 70% alcohol overnight to obtain a sterile aortic valvular scaffold.
Due to the fact that 3 to 5 litres of blood is pumped through the valve during the cardiac cycle in each minute126, the scaffold should have sufficient mechanical properties to work in such conditions. Burst strength testing is a common method to characterize the mechanical behavior of scaffolds by determining the pressure at which structural failure occurs. It should be assessed according to ISO 13938-2:2002 “Textiles - Bursting properties of fabrics - Part 2: Pneumatic method for determination of bursting strength and bursting distension” Standard. It should be noted that this test must be performed in two states, dry and wet (in physiological fluids). The strength can be different in both states. Additionally tensile properties of knitted fabrics shall be evaluated according to ISO 13934-1:2013 “Textiles - Tensile properties of fabrics - Part 1: Determination of maximum force and elongation at maximum force using the strip method”. The method specifies the determination of the maximum force and elongation at maximum force of test specimens in equilibrium with the standard atmosphere for testing and of test specimens in the wet state. Moreover the knitted scaffold should open and close properly. In127 authors showed that the knitted scaffold is stronger than the spun scaffold which remained intact under physiological loading, whereas the spun scaffold is not.
Because scaffolds will have to be in contact with blood and human fluid, the scaffold should have pH similar to pH of blood (ISO 3071:2007 “Textiles - Determination of pH of aqueous extract”).
Conclusions and future directions
Knitted structures appear to be a suitable candidate for HVTE application owing to their inherent design and structural flexibility. In addition, it is possible to design anisotropic elasticity in knitted structures, which could eventually be tailored to match the one present in the native valve. Some of the latest developments in knitted meshes use biological coatings to improve the tissue growth. This also can help to model the structure to match the anatomy of the implant site30. To make the concept of intelligent scaffold a reality, much more work needs to be done on enhancing yarn-cell specific interactions. This involves two distinct directions that will be explored in the future: modifications of the final construct and modification of yarns prior to knitting. Some promising examples of cell specific polymer surface modifications have already been reported and include enhancing the polymers with antibodies, peptides, aptamers and enzymes. The textile-based smart scaffold requires a combined input from the advanced biomechanics and textile design together in order to realize the full clinical potential of textile HV prosthesis.
The general drawback of knitting is that it inherently provides a highly porous structure that can leak upon exposure to fluids. This can be, to some extent, overcome by applying hydrogels (fibrin, HA, alginate or others62) as a sealant. A very attractive way of sealing the knitted structure is combining it with woven or non-woven fabrics. The example in Figure 18A–18D, shows a knitted leaflet on which the anisotropic sheet of PCL nanofibres was glued. A further important potential of knitted structures is that the loops architecture can guide the growth of cells and ECM secreted by the cells (Figure 18E). More research is needed to confirm if, after yarn degradation, the structure will preserve the “imprinted” elastic properties. In fact, this is important not only for HVTE but for cardiac regeneration in general. In myocardial infarction, damaged myocardium is replaced by scar tissue that is less elastic than normal myocardium. Although the scar tissue consists of viable cells capable of producing isotropic fibril ECM proteins, it is very stiff. A bioactive knitted structure is then an appealing option that may yield an elastic living construct made out of aligned ECM proteins from the cells that have colonized that yarn. To summarize, the future is bright and even the sky is not a limit (knitted yarns are also used as an element of composites use in astronauts’ space suits).
This paper also reviewed the design aspect of knitted textiles intended for HVTE. The three dimensional structure of leaflets and their unique mechanical properties (non-linearity, anisotropy, compliance) have been widely researched and reported1,2. However, these features remain widely neglected while designing the scaffolds for HV replacement. Currently available HV substitutes cannot remodel and be replaced by endogenously recruited cells129. Moreover, their structural geometry is often not analogous to native HV. This difference can later lead to clinical complications arising from behavioural mismatch at the implant anastomosis. These observations ultimately raise the importance of understanding the structure and biomechanics of an HV before adapting a textile structure from its conventional application area to a biological environment consisting of complex structure and functions such as the aortic valve. A smart valve scaffold with structural characteristics that closely resemble a native valve will present less complications which, in turn, translates to a longer-lasting durable implant.
References
- 1.Arjunon S, Rathan S, Jo H, Yoganathan AP. Aortic valve: mechanical environment and mechanobiology. Ann Biomed Eng. 2013;41(7):1331–46. doi: 10.1007/s10439-013-0785-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Chester AH, El-Hamamsy I, Butcher JT, Latif N, Bertazzo S, Yacoub MH. The living aortic valve: From molecules to function. Glob Cardiol Sci Pract. 2014;2014(1):52–77. doi: 10.5339/gcsp.2014.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yacoub MH, Kilner PJ, Birks EJ, Misfeld M. The aortic outflow and root: a tale of dynamism and crosstalk. Ann Thorac Surg. 1999;68(3 Suppl):S37–43. doi: 10.1016/s0003-4975(99)00745-6. [DOI] [PubMed] [Google Scholar]
- 4.Hasan A, Ragaert K, Swieszkowski W, Selimović S, Paul A, Camci-Unal G, et al. Biomechanical properties of native and tissue engineered heart valve constructs. J Biomech. 2014;47(9):1949–63. doi: 10.1016/j.jbiomech.2013.09.023. [DOI] [PubMed] [Google Scholar]
- 5.Yacoub MH. In Search of Living Valve Substitutes*. J Am Coll Cardiol. 2015;66(8):889–91. doi: 10.1016/j.jacc.2015.07.007. [DOI] [PubMed] [Google Scholar]
- 6.Zafar F, Hinton RB, Moore RA, Baker RS, Bryant R, Narmoneva DA, et al. Physiological Growth, Remodeling Potential, and Preserved Function of a Novel Bioprosthetic Tricuspid Valve: Tubular Bioprosthesis Made of Small Intestinal Submucosa-Derived Extracellular Matrix. J Am Coll Cardiol. 2015;66(8):877–88. doi: 10.1016/j.jacc.2015.06.1091. [DOI] [PubMed] [Google Scholar]
- 7.Khan AA, Vishwakarma SK, Bardia A, Venkateshwarulu J. Repopulation of decellularized whole organ scaffold using stem cells: an emerging technology for the development of neo-organ. J Artif Organs. 2014;17(4):291–300. doi: 10.1007/s10047-014-0780-2. [DOI] [PubMed] [Google Scholar]
- 8.Hodde J. Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng. 2002;8(2):295–308. doi: 10.1089/107632702753725058. [DOI] [PubMed] [Google Scholar]
- 9.Sun J, Tan H. Alginate-Based Biomaterials for Regenerative Medicine Applications. Materials. 2013;6(4):1285–309. doi: 10.3390/ma6041285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.El-Sherbiny IM, Yacoub MH. Hydrogel scaffolds for tissue engineering: Progress and challenges. Glob Cardiol Sci Pract. 2013;2013(3):316–42. doi: 10.5339/gcsp.2013.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Freed LE, Vunjak-Novakovic G, Biron RJ, Eagles DB, Lesnoy DC, Barlow SK, et al. Biodegradable Polymer Scaffolds for Tissue Engineering. Nat Biotechnol. 1994;12(7):689–93. doi: 10.1038/nbt0794-689. [DOI] [PubMed] [Google Scholar]
- 12.Koo M-A, Kang JK, Lee MH, Seo HJ, Kwon B-J, You KE, et al. Stimulated migration and penetration of vascular endothelial cells into poly (L-lactic acid) scaffolds under flow conditions. Biomater Res. 2014;18:7. doi: 10.1186/2055-7124-18-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chew SA, Arriaga M, Hinojosa V. Effects of surface area to volume ratio of plga scaffolds with different architectures on scaffold degradation characteristics and drug release kinetics. J Biomed Mater Res A. 2016 doi: 10.1002/jbm.a.35657. [DOI] [PubMed] [Google Scholar]
- 14.Jafari M, Paknejad Z, Rad MR, Motamedian SR, Eghbal MJ, Nadjmi N, et al. Polymeric scaffolds in tissue engineering: a literature review. J Biomed Mater Res B Appl Biomater. 2015:n/a–n/a. doi: 10.1002/jbm.b.33547. [DOI] [PubMed] [Google Scholar]
- 15.Kang C-K, Lim W-H, Kyeong S, Choe W-S, Kim H-S, Jun B-H, et al. Fabrication of biofunctional stents with endothelial progenitor cell specificity for vascular re-endothelialization. Colloids Surf B Biointerfaces. 2013;102:744–51. doi: 10.1016/j.colsurfb.2012.09.008. [DOI] [PubMed] [Google Scholar]
- 16.Lim W-H, Seo W-W, Choe W, Kang C-K, Park J, Cho H-J, et al. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thromb Vasc Biol. 2011;31(12):2798–805. doi: 10.1161/ATVBAHA.111.226134. [DOI] [PubMed] [Google Scholar]
- 17.Li Q, Wang Z, Zhang S, Zheng W, Zhao Q, Zhang J, et al. Functionalization of the surface of electrospun poly(epsilon-caprolactone) mats using zwitterionic poly(carboxybetaine methacrylate) and cell-specific peptide for endothelial progenitor cells capture. Mater Sci Eng C. 2013;33(3):1646–53. doi: 10.1016/j.msec.2012.12.074. [DOI] [PubMed] [Google Scholar]
- 18.Ji Q, Zhang S, Zhang J, Wang Z, Wang J, Cui Y, et al. Dual functionalization of poly(ε-caprolactone) film surface through supramolecular assembly with the aim of promoting in situ endothelial progenitor cell attachment on vascular grafts. Biomacromolecules. 2013;14(11):4099–107. doi: 10.1021/bm401239a. [DOI] [PubMed] [Google Scholar]
- 19.Esposito CL, Cerchia L, Catuogno S, De Vita G, Dassie JP, Santamaria G, et al. Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy. Mol Ther. 2014;22(6):1151–63. doi: 10.1038/mt.2014.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kalsi K, Lawson C, Dominguez M, Taylor P, Yacoub MH, Smolenski RT. Regulation of ecto-5’-nucleotidase by TNF-alpha in human endothelial cells. Mol Cell Biochem. 2002;232(1-2):113–9. doi: 10.1023/a:1014806916844. [DOI] [PubMed] [Google Scholar]
- 21.Sohier J, Carubelli I, Sarathchandra P, Latif N, Chester AH, Yacoub MH. The potential of anisotropic matrices as substrate for heart valve engineering. Biomaterials. 2014;35(6):1833–44. doi: 10.1016/j.biomaterials.2013.10.061. [DOI] [PubMed] [Google Scholar]
- 22.Hwang CM, Park Y, Park JY, Lee K, Sun K, Khademhosseini A, et al. Controlled cellular orientation on PLGA microfibers with defined diameters. Biomed Microdevices. 2009;11(4):739–46. doi: 10.1007/s10544-009-9287-7. [DOI] [PubMed] [Google Scholar]
- 23.Horrocks AR, Anand SC, Anand S. Handbook of Technical Textiles. Taylor & Francis; 2000. 584 p.
- 24. vasant [Internet]. [cited 2015 Sep 27]. http://www.vasantkothari.com/
- 25. Kommunikation K+ FGM und. STOLL - Flachstrickmaschinen, CMS Flachstrickmaschinen, CMS, Flat knitting machines, CMS Flat knitting machines - Reutlingen, Deutschland [Internet]. [cited 2015 Sep 27]. http://www.stoll.com/stoll-produkte .
- 26. Large Diameter | Santoni [Internet]. [cited 2015 Sep 27]. http://www.santoni.cn/en/large-diameter .
- 27. Research Journal of Textile and Apparel [Internet]. [cited 2015 Sep 27]. http://www.rjta.org/pa_inside.php?issue_id=01_1 .
- 28.Kopias K. Budowa i technologia dzianin kolumienkowych. Wydawnictwo Politechniki Łódzkiej. 2010:188 p. [Google Scholar]
- 29.Kopias K. Budowa i technologia dzianin rządkowych: praca zbiorowa. Wydawnictwo Politechniki Łódzkiej. 2013:169 p. [Google Scholar]
- 30.Singh C, Wong CS, Wang X. Medical Textiles as Vascular Implants and Their Success to Mimic Natural Arteries. J Funct Biomater. 2015;6(3):500–25. doi: 10.3390/jfb6030500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Underwood J, Underwood J. The design of 3D shape knitted preforms. 2009 [cited 2015 Sep 27]; https://researchbank.rmit.edu.au/view/rmit:6130 .
- 32.Jun Y, Kang E, Chae S, Lee S-H. Microfluidic spinning of micro- and nano-scale fibers for tissue engineering. Lab Chip. 2014;14(13):2145–60. doi: 10.1039/c3lc51414e. [DOI] [PubMed] [Google Scholar]
- 33.Tamayol A, Akbari M, Annabi N, Paul A, Khademhosseini A, Juncker D. Fiber-Based Tissue Engineering: Progress, Challenges, and Opportunities. Biotechnol Adv. 2013;31(5):669–87. doi: 10.1016/j.biotechadv.2012.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Knit Together | Jacquard Knitting Patterns [Internet]. [cited 2015 Sep 27]. http://knit-together.com/pattern/knitting-stitch-patterns/jacquard-patterns .
- 35. IMPROVED WARP KNITTING MACHINE FOR SYMMETRIC MULTI-PLIES [Internet]. [cited 2016 Feb 3]. http://www.iccm-central.org/Proceedings/ICCM16proceedings/contents/pdf/FriB/FrBA2-04ge_franzkeg221527p.pdf .
- 36.Potluri P, Sharma S, Ramgulam R. Comprehensive drape modelling for moulding 3D textile preforms. Compos Part Appl Sci Manuf. 2001;32(10):1415–24. [Google Scholar]
- 37. Nike Flyknit [Internet]. [cited 2015 Sep 27]. Available from: http://www.nike.com/us/en_us/c/ innovation/flyknit .
- 38.Sjoblom L. French Seam Studio: 3D Knitting, The First Exploration In 3D [Internet]. [cited 2015 Sep 27]. http://frenchseamstudio.blogspot.qa/2013/11/3d-knitting-first-exploration-in-3d.html .
- 39. MaxiFlex® Ultimate™ [Internet]. ATG®Glove Solutions. [cited 2015 Sep 27]. Available from: http://www.atg-glovesolutions.com/en/maxiflex-3/maxiflex-ultimate%E2%84%A2-8/34-874-34/
- 40. Bras Don’t Cause Breast Cancer, According to New Study [Internet]. [cited 2015 Sep 27]. http://jezebel.com/bras-dont-cause-breast-cancer-according-to-new-study-1630996574 .
- 41. Hosiery -images [Internet]. [cited 2015 Sep 27]. Available from http://www.cifra-spa.net/en/ products/hosiery .
- 42. CEP Compression - The Intelligent Sportswear [Internet]. [cited 2015 Sep 27]. http://www.cepcompression.com/
- 43. 2000.jpg (Obrazek JPEG, 780×320 pikseli) [Internet]. [cited 2015 Sep 27]. http://explore.speedousa.com/img/heritage/2000.jpg .
- 44.Dean B, Bhushan B. Shark-skin surfaces for fluid-drag reduction in turbulent flow: a review. Philos Trans R Soc Lond Math Phys Eng Sci. 2010;368(1929):4775–806. doi: 10.1098/rsta.2010.0201. [DOI] [PubMed] [Google Scholar]
- 45.Burkel WE, Vinter DW, Ford JW, Kahn RH, Graham LM, Stanley JC. Sequential studies of healing in endothelial seeded vascular prostheses: histologic and ultrastructure characteristics of graft incorporation. J Surg Res. 1981;30(4):305–24. doi: 10.1016/0022-4804(81)90165-7. [DOI] [PubMed] [Google Scholar]
- 46.Fujita Y, Wu MH, Ishida A, Shi Q, Walker M, Hammond WP, et al. Accelerated healing of Dacron grafts seeded by preclotting with autologous bone marrow blood. Ann Vasc Surg. 1999;13(4):402–12. doi: 10.1007/s100169900275. [DOI] [PubMed] [Google Scholar]
- 47.Pasquinelli G, Freyrie A, Preda P, Curti T, D’Addato M, Laschi R. Healing of prosthetic arterial grafts. Scanning Microsc. 1990;4(2):351–62. [PubMed] [Google Scholar]
- 48.Tolan M, Wells F, Kendall S, Large S, Wallwork J. Clinical experience with a collagen impregnated woven Dacron graft. J Cardiovasc Surg (Torino) 1995;36(4):323–7. [PubMed] [Google Scholar]
- 49.Yuksel C, Kaldor JM, James DL, Marschner S. Stitch Meshes for Modeling Knitted Clothing with Yarn-level Detail. ACM Trans Graph. 2012;31(4):37:1–37:12. [Google Scholar]
- 50.Van Lieshout M, Peters G, Rutten M, Baaijens F. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng. 2006;12(3):481–7. doi: 10.1089/ten.2006.12.481. [DOI] [PubMed] [Google Scholar]
- 51.Moreira R, Gesche VN, Hurtado-Aguilar LG, Schmitz-Rode T, Frese J, Jockenhoevel S, et al. TexMi: development of tissue-engineered textile-reinforced mitral valve prosthesis. Tissue Eng Part C Methods. 2014;20(9):741–8. doi: 10.1089/ten.tec.2013.0426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Weber M, Heta E, Moreira R, Gesche VN, Schermer T, Frese J, et al. Tissue-engineered fibrin-based heart valve with a tubular leaflet design. Tissue Eng Part C Methods. 2014;20(4):265–75. doi: 10.1089/ten.tec.2013.0258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Moreira R, Velz T, Alves N, Gesche VN, Malischewski A, Schmitz-Rode T, et al. Tissue-engineered heart valve with a tubular leaflet design for minimally invasive transcatheter implantation. Tissue Eng Part C Methods. 2015;21(6):530–40. doi: 10.1089/ten.tec.2014.0214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Singh C, Wang X. A new design concept for knitted external vein-graft support mesh. J Mech Behav Biomed Mater. 2015;48:125–33. doi: 10.1016/j.jmbbm.2015.04.001. [DOI] [PubMed] [Google Scholar]
- 55.Richardt D, Karluss A, Schmidtke C, Sievers H-H, Scharfschwerdt M. A new sinus prosthesis for aortic valve-sparing surgery maintaining the shape of the root at systemic pressure. Ann Thorac Surg. 2010;89(3):943–6. doi: 10.1016/j.athoracsur.2009.10.066. [DOI] [PubMed] [Google Scholar]
- 56.Hasegawa M, Azuma T. Mechanical properties of synthetic arterial grafts. J Biomech. 1979;12(7):509–17. doi: 10.1016/0021-9290(79)90039-3. [DOI] [PubMed] [Google Scholar]
- 57.Chitsaz S, Wenk JF, Ge L, Wisneski A, Mookhoek A, Ratcliffe MB, et al. Material properties of CorCap passive cardiac support device. Ann Thorac Surg. 2013;95(1):148–54. doi: 10.1016/j.athoracsur.2012.07.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.B. Braun Indonesia - Products - Optilene®Mesh Elastic [Internet]. [cited 2015 Sep 27]. http://www.bbraun.co.id/cps/rde/xchg/cw-bbraun-id-id/hs.xsl/products.html?prid=PRID00001223 .
- 59.Treasure T, Takkenberg JJM, Golesworthy T, Rega F, Petrou M, Rosendahl U, et al. Personalised external aortic root support (PEARS) in Marfan syndrome: analysis of 1-9 year outcomes by intention-to-treat in a cohort of the first 30 consecutive patients to receive a novel tissue and valve-conserving procedure, compared with the published results of aortic root replacement. Heart Br Card Soc. 2014;100(12):969–75. doi: 10.1136/heartjnl-2013-304913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Verbrugghe P, Verbeken E, Pepper J, Treasure T, Meyns B, Meuris B, et al. External aortic root support: a histological and mechanical study in sheep. Interact Cardiovasc Thorac Surg. 2013;17(2):334–9. doi: 10.1093/icvts/ivt165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Pepper J, Goddard M, Mohiaddin R, Treasure T. Histology of a Marfan aorta 4.5 years after personalized external aortic root support. Eur J Cardio-Thorac Surg off J Eur Assoc Cardio-Thorac Surg. 2015;48(3):502–5. doi: 10.1093/ejcts/ezu415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.El-Sherbiny IM, Yacoub MH. Hydrogel scaffolds for tissue engineering: Progress and challenges. Glob Cardiol Sci Pract. 2013;2013(3):316–42. doi: 10.5339/gcsp.2013.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Loerakker S, Argento G, Oomens CWJ, Baaijens FPT. Effects of valve geometry and tissue anisotropy on the radial stretch and coaptation area of tissue-engineered heart valves. J Biomech. 2013;46(11):1792–800. doi: 10.1016/j.jbiomech.2013.05.015. [DOI] [PubMed] [Google Scholar]
- 64.Driessen NJ, Boerboom RA, Huyghe JM, Bouten CV, Baaijens FP. Computational analyses of mechanically induced collagen fiber remodeling in the aortic heart valve. J Biomech Eng. 2003;125(4):549–57. doi: 10.1115/1.1590361. [DOI] [PubMed] [Google Scholar]
- 65.Ballotta V, Driessen-Mol A, Bouten CVC, Baaijens FPT. Strain-dependent modulation of macrophage polarization within scaffolds. Biomaterials. 2014;35(18):4919–28. doi: 10.1016/j.biomaterials.2014.03.002. [DOI] [PubMed] [Google Scholar]
- 66.van Loon SLM, Smits AIPM, Driessen-Mol A, Bouten FPTB, CVC The Immune Response in In Situ Tissue Engineering of Aortic Heart Valves. 2013 Jun 12 [cited 2015 Sep 27]; http://www.intechopen.com/books/calcific-aortic-valve-disease/the-immune-response-in-in-situ-tissue-engineering-of-aortic-heart-valves .
- 67.Syedain ZH, Lahti MT, Johnson SL, Robinson PS, Ruth GR, Bianco RW, et al. Implantation of a Tissue-engineered Heart Valve from Human Fibroblasts Exhibiting Short Term Function in the Sheep Pulmonary Artery. Cardiovasc Eng Technol. 2011;2(2):101–12. [Google Scholar]
- 68.Flanagan TC, Sachweh JS, Frese J, Schnöring H, Gronloh N, Koch S, et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A. 2009;15(10):2965–76. doi: 10.1089/ten.TEA.2009.0018. [DOI] [PubMed] [Google Scholar]
- 69.Lawrence BJ, Madihally SV. Cell colonization in degradable 3D porous matrices. Cell Adhes Migr. 2008;2(1):9–16. doi: 10.4161/cam.2.1.5884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Tissue engineering. Nat Biotechnol. 2000;18:IT56–8. [PubMed] [Google Scholar]
- 71.Langer R, Vacanti JP. Tissue engineering. Science. 1993;260(5110):920–6. doi: 10.1126/science.8493529. [DOI] [PubMed] [Google Scholar]
- 72.Dar A, Shachar M, Leor J, Cohen S. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng. 2002;80(3):305–12. doi: 10.1002/bit.10372. [DOI] [PubMed] [Google Scholar]
- 73.Zeltinger J, Sherwood JK, Graham DA, Müeller R, Griffith LG. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001;7(5):557–72. doi: 10.1089/107632701753213183. [DOI] [PubMed] [Google Scholar]
- 74.Ranucci CS, Moghe PV. Substrate microtopography can enhance cell adhesive and migratory responsiveness to matrix ligand density. J Biomed Mater Res. 2001;54(2):149–61. doi: 10.1002/1097-4636(200102)54:2<149::aid-jbm1>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- 75.Balgude AP, Yu X, Szymanski A, Bellamkonda RV. Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. Biomaterials. 2001;22(10):1077–84. doi: 10.1016/s0142-9612(00)00350-1. [DOI] [PubMed] [Google Scholar]
- 76.Treasure T, Takkenberg JJM, Golesworthy T, Rega F, Petrou M, Rosendahl U, et al. Personalised external aortic root support (PEARS) in Marfan syndrome: analysis of 1–9 year outcomes by intention-to-treat in a cohort of the first 30 consecutive patients to receive a novel tissue and valve-conserving procedure, compared with the published results of aortic root replacement. Heart. 2014;100(12):969–75. doi: 10.1136/heartjnl-2013-304913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.O’Brien FJ, Harley BA, Yannas IV, Gibson LJ. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials. 2005;26(4):433–41. doi: 10.1016/j.biomaterials.2004.02.052. [DOI] [PubMed] [Google Scholar]
- 78.Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2002;23(6):475–85. doi: 10.1053/ejvs.2002.1654. [DOI] [PubMed] [Google Scholar]
- 79.Wang YC, Ho C-C. Micropatterning of proteins and mammalian cells on biomaterials. FASEB J Off Publ Fed Am Soc Exp Biol. 2004;18(3):525–7. doi: 10.1096/fj.03-0490fje. [DOI] [PubMed] [Google Scholar]
- 80.Zeltinger J, Sherwood JK, Graham DA, Müeller R, Griffith LG. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 2001;7(5):557–72. doi: 10.1089/107632701753213183. [DOI] [PubMed] [Google Scholar]
- 81.Yannas IV, Lee E, Orgill DP, Skrabut EM, Murphy GF. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A. 1989;86(3):933–7. doi: 10.1073/pnas.86.3.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Wu W, Allen RA, Wang Y. Fast degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neo-artery. Nat Med. 2012;18(7):1148–53. doi: 10.1038/nm.2821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Li W-J, Laurencin CT, Caterson EJ, Tuan RS, Ko FK. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res. 2002;60(4):613–21. doi: 10.1002/jbm.10167. [DOI] [PubMed] [Google Scholar]
- 84.Lee CH, Shin HJ, Cho IH, Kang Y-M, Kim IA, Park K-D, et al. Nanofiber alignment and direction of mechanical strain affect the ECM production of human ACL fibroblast. Biomaterials. 2005;26(11):1261–70. doi: 10.1016/j.biomaterials.2004.04.037. [DOI] [PubMed] [Google Scholar]
- 85.Ranucci CS, Kumar A, Batra SP, Moghe PV. Control of hepatocyte function on collagen foams: sizing matrix pores toward selective induction of 2-D and 3-D cellular morphogenesis. Biomaterials. 2000;21(8):783–93. doi: 10.1016/s0142-9612(99)00238-0. [DOI] [PubMed] [Google Scholar]
- 86.Walboomers XF, Croes HJ, Ginsel LA, Jansen JA. Contact guidance of rat fibroblasts on various implant materials. J Biomed Mater Res. 1999;47(2):204–12. doi: 10.1002/(sici)1097-4636(199911)47:2<204::aid-jbm10>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- 87.Lampin M, Warocquier-Clérout null, Legris C, Degrange M, Sigot-Luizard MF. Correlation between substratum roughness and wettability, cell adhesion, and cell migration. J Biomed Mater Res. 1997;36(1):99–108. doi: 10.1002/(sici)1097-4636(199707)36:1<99::aid-jbm12>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- 88.Pattison MA, Wurster S, Webster TJ, Haberstroh KM. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials. 2005;26(15):2491–500. doi: 10.1016/j.biomaterials.2004.07.011. [DOI] [PubMed] [Google Scholar]
- 89.Park GE, Pattison MA, Park K, Webster TJ. Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials. 2005;26(16):3075–82. doi: 10.1016/j.biomaterials.2004.08.005. [DOI] [PubMed] [Google Scholar]
- 90.Mondalek FG, Lawrence BJ, Kropp BP, Grady BP, Fung K-M, Madihally SV, et al. The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. Biomaterials. 2008;29(9):1159–66. doi: 10.1016/j.biomaterials.2007.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Lee CR, Grodzinsky AJ, Spector M. The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. Biomaterials. 2001;22(23):3145–54. doi: 10.1016/s0142-9612(01)00067-9. [DOI] [PubMed] [Google Scholar]
- 92.Sieminski AL, Hebbel RP, Gooch KJ. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp Cell Res. 2004;297(2):574–84. doi: 10.1016/j.yexcr.2004.03.035. [DOI] [PubMed] [Google Scholar]
- 93.Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys J. 2000;79(1):144–52. doi: 10.1016/S0006-3495(00)76279-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Pelham RJ, Wang Yl. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci U S A. 1997;94(25):13661–5. doi: 10.1073/pnas.94.25.13661. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Grashow JS, Yoganathan AP, Sacks MS. Biaixal stress–stretch behavior of the mitral valve anterior leaflet at physiologic strain rates. Ann Biomed Eng. 2006;34(2):315–25. doi: 10.1007/s10439-005-9027-y. [DOI] [PubMed] [Google Scholar]
- 96.Chen H-C, Hu Y-C. Bioreactors for tissue engineering. Biotechnol Lett. 2006;28(18):1415–23. doi: 10.1007/s10529-006-9111-x. [DOI] [PubMed] [Google Scholar]
- 97.Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV. In vitro characterization of chitosan-gelatin scaffolds for tissue engineering. Biomaterials. 2005;26(36):7616–27. doi: 10.1016/j.biomaterials.2005.05.036. [DOI] [PubMed] [Google Scholar]
- 98.Ingber DE. Cellular mechanotransduction: putting all the pieces together again. FASEB J Off Publ Fed Am Soc Exp Biol. 2006;20(7):811–27. doi: 10.1096/fj.05-5424rev. [DOI] [PubMed] [Google Scholar]
- 99.Vandevondele S, Vörös J, Hubbell JA. RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion. Biotechnol Bioeng. 2003;82(7):784–90. doi: 10.1002/bit.10625. [DOI] [PubMed] [Google Scholar]
- 100.Laschke MW, Harder Y, Amon M, Martin I, Farhadi J, Ring A, et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng. 2006;12(8):2093–104. doi: 10.1089/ten.2006.12.2093. [DOI] [PubMed] [Google Scholar]
- 101.Nomi M, Atala A, Coppi PD, Soker S. Principals of neovascularization for tissue engineering. Mol Aspects Med. 2002;23(6):463–83. doi: 10.1016/s0098-2997(02)00008-0. [DOI] [PubMed] [Google Scholar]
- 102.Hubbell JA. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol. 2003;14(5):551–8. doi: 10.1016/j.copbio.2003.09.004. [DOI] [PubMed] [Google Scholar]
- 103.Tillman J, Ullm A, Madihally SV. Three-dimensional cell colonization in a sulfate rich environment. Biomaterials. 2006;27(32):5618–26. doi: 10.1016/j.biomaterials.2006.07.006. [DOI] [PubMed] [Google Scholar]
- 104.Smits AIPM, Ballotta V, Driessen-Mol A, Bouten CVC, Baaijens FPT. Shear flow affects selective monocyte recruitment into MCP-1-loaded scaffolds. J Cell Mol Med. 2014;18(11):2176–88. doi: 10.1111/jcmm.12330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Ballotta V, Smits AIPM, Driessen-Mol A, Bouten CVC, Baaijens FPT. Synergistic protein secretion by mesenchymal stromal cells seeded in 3D scaffolds and circulating leukocytes in physiological flow. Biomaterials. 2014;35(33):9100–13. doi: 10.1016/j.biomaterials.2014.07.042. [DOI] [PubMed] [Google Scholar]
- 106.Tokiwa Y, Calabia BP, Ugwu CU, Aiba S. Biodegradability of Plastics. Int J Mol Sci. 2009;10(9):3722–42. doi: 10.3390/ijms10093722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Pantani R, Sorrentino A. Influence of crystallinity on the biodegradation rate of injection-moulded poly(lactic acid) samples in controlled composting conditions. Polym Degrad Stab. 2013;98(5):1089–96. [Google Scholar]
- 108. ISO 5840-1:2015(en) Cardiovascular implants — Cardiac valve prostheses — Part 1: General requirements [Internet]. [cited 2015 Sep 27]. https://www.iso.org/obp/ui/#iso:std:iso:5840:-1:ed-1:v1:en .
- 109. ISO 5840-2:2015(en) [Internet]. [cited 2015 Sep 27]. https://www.iso.org/obp/ui/#iso:std:51314:en .
- 110. ISO 5840-3:2013(en) [Internet]. [cited 2015 Sep 27]. https://www.iso.org/obp/ui/#iso:std:iso:5840:-3:ed-1:v1:en .
- 111.Struszczyk MH, Olejnik M. Assessment of Prospect of Textile Technologies for Medical Devices. Fibres Text East Eur [Internet]. 2012 [cited 2015 Nov 3];Nr 6A (95). http://yadda.icm.edu.pl/baztech/element/bwmeta1.element.baztech-article-BPW7-0024-0010 .
- 112.Valente TAM, Silva DM, Gomes PS, Fernandes MH, Santos JD, Sencadas V. Effect of sterilization methods on electrospun poly(lactic acid) (PLA) fibre alignment for biomedical applications. ACS Appl Mater Interfaces. 2016 doi: 10.1021/acsami.5b10869. [DOI] [PubMed] [Google Scholar]
- 113.Cheung DY, Duan B, Butcher JT. Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions. Expert Opin Biol Ther. 2015;15(8):1155–72. doi: 10.1517/14712598.2015.1051527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Masoumi N, Annabi N, Assmann A, Larson BL, Hjortnaes J, Alemdar N, et al. Tri-layered elastomeric scaffolds for engineering heart valve leaflets. Biomaterials. 2014;35(27):7774–85. doi: 10.1016/j.biomaterials.2014.04.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Weber M, Gonzalez de Torre I, Moreira R, Frese J, Oedekoven C, Alonso M, et al. Multiple-Step Injection Molding for Fibrin-Based Tissue-Engineered Heart Valves. Tissue Eng Part C Methods. 2015;21(8):832–40. doi: 10.1089/ten.tec.2014.0396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Missirlis YF, Chong M. Aortic valve mechanics–Part I: material properties of natural porcine aortic valves. J Bioeng. 1978;2(3-4):287–300. [PubMed] [Google Scholar]
- 117.Lee JM, Courtman DW, Boughner DR. The glutaraldehyde-stabilized porcine aortic valve xenograft. I. Tensile viscoelastic properties of the fresh leaflet material. J Biomed Mater Res. 1984;18(1):61–77. doi: 10.1002/jbm.820180108. [DOI] [PubMed] [Google Scholar]
- 118.Sauren AAHJ, van Hout MC, van Steenhoven AA, Veldpaus FE, Janssen JD. The mechanical properties of porcine aortic valve tissues. J Biomech. 1983;16(5):327–37. doi: 10.1016/0021-9290(83)90016-7. [DOI] [PubMed] [Google Scholar]
- 119.Vesely I, Noseworthy R. Micromechanics of the fibrosa and the ventricularis in aortic valve leaflets. J Biomech. 1992;25(1):111–3. doi: 10.1016/0021-9290(92)90249-z. [DOI] [PubMed] [Google Scholar]
- 120.Kiefer P, Gruenwald F, Kempfert J, Aupperle H, Seeburger J, Mohr FW, et al. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann Thorac Surg. 2011;92(1):155–60. doi: 10.1016/j.athoracsur.2011.03.020. [DOI] [PubMed] [Google Scholar]
- 121.Spethmann S, Dreger H, Schattke S, Baldenhofer G, Saghabalyan D, Stangl V, et al. Doppler haemodynamics and effective orifice areas of Edwards SAPIEN and CoreValve transcatheter aortic valves. Eur Heart J - Cardiovasc Imaging. 2012:jes021. doi: 10.1093/ehjci/jes021. [DOI] [PubMed] [Google Scholar]
- 122.Gauvin R, Guillemette M, Galbraith T, Bourget J-M, Larouche D, Marcoux H, et al. Mechanical properties of tissue-engineered vascular constructs produced using arterial or venous cells. Tissue Eng Part A. 2011;17(15-16):2049–59. doi: 10.1089/ten.TEA.2010.0613. [DOI] [PubMed] [Google Scholar]
- 123.Mol A, Smits AIPM, Bouten CVC, Baaijens FPT. Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices. 2009;6(3):259–75. doi: 10.1586/erd.09.12. [DOI] [PubMed] [Google Scholar]
- 124.Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem. 1996;29(3):225–9. doi: 10.1016/0009-9120(96)00003-6. [DOI] [PubMed] [Google Scholar]
- 125.Marcin Henryk Struszczyk AK. ULTRA-LIGHT KNITTED STRUCTURES FOR APPLICATION IN UROLOGINECOLOGY AND GENERAL SURGERY – OPTIMIZATION OF STRUCTURE. 2011.
- 126.Butcher JT, Mahler GJ, Hockaday LA. Aortic valve disease and treatment: the need for naturally engineered solutions. Adv Drug Deliv Rev. 2011;63(4-5):242–68. doi: 10.1016/j.addr.2011.01.008. [DOI] [PubMed] [Google Scholar]
- 127.van Lieshout MI, Vaz CM, Rutten MCM, Peters GWM, Baaijens FPT. Electrospinning versus knitting: two scaffolds for tissue engineering of the aortic valve. J Biomater Sci Polym Ed. 2006;17(1-2):77–89. doi: 10.1163/156856206774879153. [DOI] [PubMed] [Google Scholar]
- 128.Albert Liberski. Figure 20 [Internet]. 2015 [cited 2015 Sep 28]. https://www.youtube.com/watch?v=bE73wvlEknU .
- 129.Kheradvar A, Groves EM, Goergen CJ, Alavi SH, Tranquillo R, Simmons CA, et al. Emerging trends in heart valve engineering: Part II. Novel and standard technologies for aortic valve replacement. Ann Biomed Eng. 2015;43(4):844–57. doi: 10.1007/s10439-014-1191-5. [DOI] [PubMed] [Google Scholar]